LncRNA CASC2 Regulate Cell Proliferation and Invasion by Targeting miR-155/SOCS1 Axis in Hepatocellular Carcinoma
暂无分享,去创建一个
[1] Zhiqiang Li,et al. The lncRNA CASC2 Modulates Hepatocellular Carcinoma Cell Sensitivity and Resistance to TRAIL Through Apoptotic and Non-Apoptotic Signaling , 2022, Frontiers in Oncology.
[2] C. Qin,et al. Functional role of miR‑155 in physiological and pathological processes of liver injury (Review). , 2021, Molecular medicine reports.
[3] Shinn-Ying Ho,et al. Novel miRNA signature for predicting the stage of hepatocellular carcinoma , 2020, Scientific Reports.
[4] Juan Yang,et al. The expression of lncRNA XIST in hepatocellular carcinoma cells and its effect on biological function. , 2020, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.
[5] Xiaopeng Xu,et al. miR-155-5p increases the sensitivity of liver cancer cells to adriamycin by regulating ATG5-mediated autophagy. , 2020, Neoplasma (Bratislava).
[6] Miao Wang,et al. LncRNA CTBP1-AS2 Promotes Cell Proliferation in Hepatocellular Carcinoma by Regulating miR-623/Cyclin D1 Axis. , 2020, Cancer biotherapy & radiopharmaceuticals.
[7] F. Piñero,et al. Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment , 2020, Cells.
[8] M. Taheri,et al. The role of long non-coding RNA CASC2 in the carcinogenesis process. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[9] Yang-Hsiang Lin. Crosstalk of lncRNA and Cellular Metabolism and Their Regulatory Mechanism in Cancer , 2020, International journal of molecular sciences.
[10] Wei Zhang,et al. SOCS1 blocks G1-S transition in hepatocellular carcinoma by reducing the stability of the CyclinD1/CDK4 complex in the nucleus , 2020, Aging.
[11] Z. Hou,et al. Long Non-coding RNA MALAT1 Promotes Angiogenesis and Immunosuppressive Properties of HCC Cells by sponging miR-140. , 2019, American journal of physiology. Cell physiology.
[12] Shuwei Chen,et al. Long noncoding RNA NEAT1 suppresses sorafenib sensitivity of hepatocellular carcinoma cells via regulating miR‐335–c‐Met , 2019, Journal of cellular physiology.
[13] Ping Chen,et al. Long non-coding RNA CASC2 enhances berberine-induced cytotoxicity in colorectal cancer cells by silencing BCL2 , 2019, Molecular medicine reports.
[14] Xiaodong Zhang,et al. Long non-coding RNA HOTAIR promotes exosome secretion by regulating RAB35 and SNAP23 in hepatocellular carcinoma , 2019, Molecular Cancer.
[15] W. Zhang,et al. Long non-coding RNA cancer susceptibility candidate 2 inhibits the cell proliferation, invasion and angiogenesis of cervical cancer through the MAPK pathway. , 2019, European review for medical and pharmacological sciences.
[16] Haitao Zhao,et al. Comprehensive analysis of a ceRNA network reveals potential prognostic cytoplasmic lncRNAs involved in HCC progression , 2019, Journal of cellular physiology.
[17] M. Radwan,et al. RASSF1A and SOCS1 genes methylation status as a noninvasive marker for hepatocellular carcinoma. , 2019, Cancer biomarkers : section A of Disease markers.
[18] A. Pillai,et al. Goals and targets for personalized therapy for HCC , 2019, Hepatology International.
[19] Bin Zhang,et al. LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation , 2018, EBioMedicine.
[20] M. Ahmadvand,et al. Over expression of circulating miR-155 predicts prognosis in diffuse large B-cell lymphoma. , 2018, Leukemia research.
[21] M. Khaniani,et al. Simultaneous downregulation of miR‐21 and miR‐155 through oleuropein for breast cancer prevention and therapy , 2018, Journal of cellular biochemistry.
[22] Qian Qian,et al. SOCS1 is associated with clinical progression and acts as an oncogenic role in triple‐negative breast cancer , 2018, IUBMB life.
[23] Lixiang Jiang,et al. Long non-coding RNA CASC2 inhibits tumorigenesis via the miR-181a/PLXNC1 axis in melanoma , 2018, Acta biochimica et biophysica Sinica.
[24] Zhangli Liu,et al. Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[25] Zeping Han,et al. Overexpression of Long Non‐Coding RNA MEG3 Inhibits Proliferation of Hepatocellular Carcinoma Huh7 Cells via Negative Modulation of miRNA‐664 , 2017, Journal of cellular biochemistry.
[26] Xiangjian Chen,et al. Low expression of long noncoding RNA CASC2 indicates a poor prognosis and promotes tumorigenesis in thyroid carcinoma. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[27] Dalong Song,et al. MiR‐155 inhibits proliferation and invasion by directly targeting PDCD4 in non‐small cell lung cancer , 2017, Thoracic cancer.
[28] Jianfeng Zhou,et al. Overexpression of long non-coding RNA cancer susceptibility 2 inhibits cell invasion and angiogenesis in gastric cancer , 2017, Molecular medicine reports.
[29] Meng Xu,et al. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis , 2017, Molecular Cancer.
[30] Chunhong Hu,et al. Modulation of CASC2/miR-21/PTEN pathway sensitizes cervical cancer to cisplatin. , 2017, Archives of biochemistry and biophysics.
[31] A. Ozakyol. Global Epidemiology of Hepatocellular Carcinoma (HCC Epidemiology) , 2017, Journal of Gastrointestinal Cancer.
[32] I. Lossos,et al. miR-155 regulates HGAL expression and increases lymphoma cell motility. , 2012, Blood.